Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! 2nd Global Bioequivalence Harmonisation Initiative – a great success Quality Management Systems in Early Phase Trials Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
IMPD Statistical services Protocol development Biometrics Transdermal therapeutic system Rhine Main area Spacious archive US CFR 21 Part 11 Anaesthesiologist Life cycle management Efficacy ANVISA Sequential designs HTA Early phase Quality Xerostomia Female adolescents Paediatricians Scientific advice First in human Edema Centralised procedure DFI Phase IV HRT Biopharmaceutics CRO Clinical pharmacology unit Data Validation Plan SDV Absorption windows Standard operating procedure Axis HPA axis US FDA SocraTec C&S Immunogenicity Patients Pituitary Statistical programming Design development Local tolerability Elpro Clinical trials Ophthalmology Network Phase IIa trials Postmenopausal women CRF GLP Product development Audit Recruitment rates Creativity EMA Monitoring Drug Food Interaction Pharmacology Pilot study AGAH Allergy Patch adhesion TTS Phase II Metered dose inhaler Phase III Pharmacodynamic studies SAS Good Clinical Practice MDI Cardiovascular surveillance Sample size estimation CDSIC Standardisation SOP based Authorities GCP Cough Endpoint Steady state IB Central surveillance system Sore throat Consultancy Subcontractor qualification MMM Macular Gynaecological trials Project Management Phase I Clinical development program CDISC Referral system Database OTC ICF Expert Experience Copyright PASS Protocol Bioavailability Competence Biopharmaceutical Biosimilars Dose linearity Contraception Clinical study Pharmacokinetics Dry powder inhaler Uveitis Pragmatism Dry eye Informed Consent Procedure Charcoal Patch Training Dermal irritation Statistical Analysis Plan CRA Highly variable drugs PAES Legal Information CDM Lung Inspection Eye disease DUS Clinical Monitoring Common cold WinNonlin COPD Patient recruitment Non interventional Phase IIb trials Ovulation inhibition Children Pulse oximetry plethysmography NIS FIM Adrenocortical Intensive assessment station Quality Assurance IEC ADAM Ophthalmologist Data Management Plan FDA Ocular tolerability Oncology Healthy subjects GCP training Scientific expertise Sensitisation trials Legal representative Drug Drug Interaction Hormone replacement therapy Data management In vitro in vivo correlation Quality Management System Degeneration Thuringia Glaucoma Auditing MCID Absorption Bioequivalence Oncological patients Phase I Unit CDASH Slit lamp microscopy Feasibility Oncologic network Pharmacokintetics DPI Investigators brochure Asthma Inhalatives Source Data Verification DDI Post authorisation Hypothalamic Safety Ophthalmological trials IVIVC  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page